With the nation focused on the delivery of a COVID vaccine, the CDC wants to ensure that older individuals are protected against other prevalent yet preventable diseases that can lead to severe health complications and even hospitalization. Vaccine demand declined an average of more than 60 percent across adult vaccines during the height of pandemic.

One of those adult vaccines is Shingrix for the prevention of shingles.

Joining me today to talk about shingles and the Shingrix vaccine is Dr. Leonard Friedland. Dr. Friedland is Vice President, Director Scientific Affairs and Public Health at GSK Vaccines and a physician.